Treatment of Thin Endometrium
OtherThis is a trial to improve endometrial thickness by autologous injection of PRP into the Uterine Cavity compared with CSF or no treatment.
NCT Number: NCT03166345
Platelets rich plasma is simple source of growth factors and cytokines that can regulate endometrial growth for subgroup of thin endometrium women. It is an autologous source of this enhancing factors; therefore, there os no risk of using it within the same participant.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Gannah IVF unit, Gannah Hospital, Giza, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is a trial to improve endometrial thickness by autologous injection of PRP into the Uterine Cavity compared with CSF or no treatment.
Time frame: 2 days
How the endometrium would respond after 2 days of PRP
Time frame: 4 weeks or beyond after embryo Transfer
Registered fetal heartbeat 4 weeks or beyond after embryo transfer.
Ibn Sina Hospital
Other Gov
Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium For IVF Women
Acronym: PRPITM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.